Literature DB >> 2605118

Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies.

I Van Riet1, C Heirman, P Lacor, M De Waele, K Thielemans, B Van Camp.   

Abstract

To investigate whether B lymphocytes are involved in the malignant cell clone of multiple myeloma (MM), we performed immunoglobulin gene rearrangement analysis of mononuclear cells and separated B lymphocytes, isolated from bone marrow and peripheral blood of MM patients. The B lymphocytes were separated by immunomagnetic beads, coated with an HLA class II specific antibody. Southern blot analysis with a JH probe revealed in the bone marrow of three out of seven patients identical immunoglobulin gene rearrangements in the B lymphocytes when compared to the plasma cells. Out of 10 patients, two patients with a high tumour burden were found to have monoclonal B lymphocytes in the peripheral blood. These results suggest that B lymphocytes in the bone marrow are part of the myeloma clone and that they can circulate in the peripheral blood. Although previous studies indicated that the ratio of K to lambda bearing lymphocytes in the peripheral blood can provide evidence for B cell monoclonality, we did not find a correlation between the results of K/lambda analysis and immunoglobulin gene rearrangement.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2605118     DOI: 10.1111/j.1365-2141.1989.tb07742.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  Phenotypic and genotypic alterations characterize patients bearing plasma cell dyscrasias with a high M-component.

Authors:  C Greco; F Ameglio; F Alvino; A Mosiello; A M Cianciulli; I Venturo; G Del Monte; M Giampaolo; A W Tong; G M Gandolfo
Journal:  Cell Prolif       Date:  1999-08       Impact factor: 6.831

Review 2.  Differentiation and cancer: the conditional autonomy of phenotype.

Authors:  R G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

3.  Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma.

Authors:  Y Levy; C Schmitt; A Tsapis; J C Brouet; J P Fermand
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

4.  Detection of clonal immunoglobulin gene rearrangements in the peripheral blood progenitor cells of patients with multiple myeloma: the potential role of purging with CD34 positive selection.

Authors:  R G Owen; A P Haynes; P A Evans; R J Johnson; A C Rawstron; G McQuaker; G M Smith; M C Galvin; D L Barnard; N H Russell; J A Child; G J Morgan
Journal:  Clin Mol Pathol       Date:  1996-04

5.  Generation of T cell clones binding F(ab')2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy.

Authors:  A Osterborg; M Masucci; S Bergenbrant; G Holm; A K Lefvert; H Mellstedt
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors.

Authors:  D M Hilbert; M Y Shen; U R Rapp; S Rudikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

Review 7.  Homing behaviour of the malignant cell clone in multiple myeloma.

Authors:  I Van Riet; K Vanderkerken; C de Greef; B Van Camp
Journal:  Med Oncol       Date:  1998-09       Impact factor: 3.064

Review 8.  Immunoglobulin variable region structure and B-cell malignancies.

Authors:  H Kiyoi; T Naoe
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.319

9.  Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas.

Authors:  P Corradini; M Boccadoro; C Voena; A Pileri
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

10.  The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.

Authors:  D Billadeau; G Ahmann; P Greipp; B Van Ness
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.